Optical imaging developer Spectral Molecular Imaging (SMI) of Beverly Hills, CA, will receive $750,000 in research funding from the U.S. National Institutes of Health (NIH) through its collaboration with Omega Optical of Brattleboro, VT.
The companies are developing a new class of medical endoscopes with proprietary multispectral imaging technology. The new Omega-SMI development program, scheduled for two years, focuses on completing a prototype fast multispectral endoscope and its preclinical testing.
The phase II award from NIH's National Cancer Institute was granted after successful completion of a $100,000 phase I feasibility study earlier this year.
Related Reading
Spectral Molecular taps chief scientist, June 30, 2010
Cascade Tech buys Spectral Molecular, March 19, 2010
Copyright © 2010 AuntMinnie.com
